Background: Low-dose glucocorticoids are frequently used for the management of
rheumatoid arthritis (RA) and other chronic conditions, but the safety of long-term use …

Immunomodulatory therapy for rheumatoid arthritis (RA) carries risk for infectious
complications. Understanding the risks of different therapeutic options is essential for …

Background: Weight gain and hypertension are well known adverse effects of treatment with
high-dose glucocorticoids. Objective: To evaluate the effects of 2 years of low-dose …

Although low-dose and short-term glucocorticoid use is extremely common and effective in
RA management, increasing evidence of toxicity has led experts to begin recommending …

Oral corticosteroids (OCS) are commonly prescribed for acute, self‐limited conditions,
despite studies demonstrating toxicity. Studies evaluating longitudinal OCS prescribing in …

Objectives To evaluate the success rate of glucocorticoid discontinuation and to study which
factors are associated with successful discontinuation. Methods Data from two treat-to-target …

Objective Glucocorticoids are recommended for short‐term use in rheumatoid arthritis (RA),
but many patients continue receiving long‐term therapy. We evaluated the variability in …

Objectives Over one-third of patients with RA exhibit evidence of fibromyalgianess, which is
associated with higher rates of disability and inadequate responsiveness to RA treatment …

Objective To evaluate if initially starting glucocorticoid (GC) bridging leads to a higher
probability of long-term GC and biological (b) DMARD use in rheumatoid arthritis (RA) …

Patients with inflammatory rheumatic and musculoskeletal diseases (iRMDs) such as
rheumatoid arthritis, connective tissue diseases, vasculitides and spondyloarthropathies are …